Assessment of the usefulness of antithrombin-iii in the management of disseminated intravascular coagulation in obstetrically ill patients

Clinical and Applied Thrombosis/Hemostasis

Volumn 16, Issue 6, 2010, Pages 688-693

  Kobayashi, Aiko ^a   Matsuda, Yoshio ^a   Mitani, Minoru ^a   Makino, Yasuo ^a   Ohta, Hiroaki ^a  

^a TOKYO WOMEN S MEDICAL UNIVERSITY MEDICAL CENTER EAST   (Japan)

Author keywords

albumin; antithrombin III; DIC score; obstetric disseminated intravascular coagulation

Indexed keywords

ANTITHROMBIN III; SERUM ALBUMIN; URIC ACID;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG EFFECT; FEMALE; HELLP SYNDROME; HUMAN; LABORATORY TEST; MEDICAL RECORD; OBSTETRICS; PREECLAMPSIA; PRIORITY JOURNAL; SCORING SYSTEM; URIC ACID BLOOD LEVEL;

ADULT; ANTITHROMBIN III; BLOOD PROTEINS; DISSEMINATED INTRAVASCULAR COAGULATION; FEMALE; HUMANS; SERUM ALBUMIN; URIC ACID;

EID: 78650387915     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/1076029609344085     Document Type: Article

References (27)

1. Cunningham FG, Leveno KJ, Bloom SL, Hauth JC, Gilstrap LC III, Wenstrom KD Obstetrical hemorrhage. In: Cunningham FG, Leveno KJ, Bloom SL, Hauth JC, Gilstrap LC III, Wenstrom KD, eds. Williams Obstetrics. 22 nd ed. New York, NY: McGraw-Hill ; 2005: 843-849.
2. Fourrier F., Chopin C., Goudemand J., et al. Septic shock, multiple organ failure, and disseminated intravascular coagulation. Compared patterns of antithrombin III, protein C, and protein S deficiencies. Chest. 1992 ; 101 (3). 816-823.
3. Mangione S., Giarratano A. The role of AT-III in critical patients in obstetrics. Minerva Anestesiol. 2002 ; 68 (5). 449-453.
4. Wiedermann CJ, Hoffmann JN, Juers M., et al, and the KyberSept Investigators. High-dose antithrombin III in the treatment of severe sepsis in patients with a high risk of death: efficacy and safety. Crit Care Med. 2006 ; 34 (2). 285-292.
5. Warren BL, Eid A., Singer P., et al, for the KyberSept Trial Study Group. Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial. JAMA. 2001 ; 286 (15). 1869-1878.
6. Aibiki M., Fukuoka N., Umakoshi K., Ohtsubo S., Kikuchi S. Serum albumin levels anticipate antithrombin III activities before and after antithrombin III agent in critical patients with disseminated intravascular coagulation. Shock. 2007 ; 27 (2). 139-144. (Pubitemid 46105829)
7. Terao T., Maki M., Ikenoue T. A prospective study in 38 patients with abruptio placentae of 70 cases complicated by DIC. Asia Oceania J Obstet Gynaecol. 1987 ; 13 (1). 1-13.
8. Matsuda Y., Maeda T., Kouno S. Fetal/neonatal outcome in abruptio placentae during preterm gestation. Semin Thromb Hemost. 2005 ; 31 (3). 327-333.
9. Kung HC, Hoyart DL, Xu J., Murphy SL Deaths: final data for 2005. Nat Vital Stat Rep. 2008 ; 56 (10). 1-120.
10. Cunningham FG, Gant NF, Leveno KJ, Gilstrap LC, Hauth JC, Wenstrom KD Preterm birth. In: Cunningham FG, Gant NF, Leveno KJ, Gilstrap LC, Hauth JC, Wenstrom KD, eds. Williams Obstetrics. 2 1st ed. New York, NY: McGraw-Hill ; 2001: 690-696.
11. VD-Gracia P. Acute fatty liver and HELLP syndrome: two distinct pregnancy disorders. Int J Gynecol Obstet. 2001 ; 73 (3). 215-220.
12. Sakata Y., Yoshida N., Matsuda M., Aoki N. Treatment of DIC with antithrombin III concentrates. In: Abe T, Yamanaka M, eds. Disseminated Intravascular Coagulation. Tokyo, Japan: University of Tokyo Press ; 1983: 307-316.
13. Fourrier F., Jourdain M., Tournoys A. Clinical trial results with antithrombin III in sepsis. Crit Care Med. 2000 ; 28 (9 suppl). S38 - S43.
14. Fleck A., Raines G., Hawker F., et al. Increased vascular permeability: a major cause of hypoalbuminemia in disease and injury. Lancet. 1985 ; 1 (8432). 781-785.
15. Gerbasi FR, Bottoms SF, Farag MA, Mammen EF Increased intravascular coagulation associated with pregnancy. Obstet Gynecol. 1990 ; 75 (3 pt 1). 385-389.
16. Patemoster D., Stella A., Simioni P., Trovo S., Plebani P., Girolami A. Clotting inhibitors and fibronectin as potencial markers in preeclampsia. Int J Gynecol Obstet. 1994 ; 47 (3). 215-221.
17. Kobayashi T., Terao T. Preeclampsia as chronic disseminated intravascular coagulation. Study of two parameters: thrombin-antithrombin III complex and D-dimers. Gynecol Obstet Invest. 1987 ; 24 (3). 170-178.
18. Maki M. Antithrombin III. Recent advances in obstetrical disseminated intravascular coagulation. Biomed Prog. 1992 ; 5 (1). 5-8.
19. Barton JR, Sibai BM Care of the pregnancy complicated by HELLP syndrome. Obstet Gynecol Clin North Am. 1991 ; 18 (2). 165-179.
20. Riley CA, Latham PS, Romero R., Duffy TP Acute fatty liver of pregnancy. A reassessment based on observations in nine patients. Ann Intern Med. 1987 ; 106 (5). 703-706.
21. Bremme SHK, Blomback M. Acquired deficiency of antithrombin in association with a hypercoagulable state and impaired function of liver and/or kidney in preeclampsia. Blood Coagul Fibrinolysis. 1997 ; 8 (4). 232-238.
22. Leyva F., Anker S., Swan JW, et al. Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure. Eur Heart J. 1997 ; 18 (5). 858-865. (Pubitemid 27208159)
23. Kang DH, Finch J., Nakagawa T., et al. Uric acid, endothelial dysfunction and pre-eclampsia: searching for a pathogenetic link. J Hypertens. 2004 ; 22 (2). 229-235.
24. Thijs LG, Eisele B., Keinecke HO, et al. Antithrombin III in patients with severe sepsis: a dosage regimen finding and pharmacokinetic study. Intensive Care Med. 1997 ; 23 (suppl 1). S58.
25. Harper PL, Park GR, Carrell RW The plasma turn-over of transfused antithrombin concentrate in patients with acquired antithrombin deficiency. Transfus Med. 1996 ; 6 (1). 45-50.
26. Nakagawa M., Tsuji H., Matsumura H. Changes in post-administered anti-thrombin III activity in congenital AT III deficiency patients [in Japanese]. Shinryo to Shinyaku. 1985 ; 22: 2139-2146.
27. Collen D. Schetz J. de Cock F., Holmer E., Verstraete M. Metabolism of antithrombin III (heparin cofactor) in mm: effects of venous thrombosis and of heparin administration. Eur J Clin Invest. 1971 ; 7 (1). 27-35.